Paul Sax
@paulsaxmd.bsky.social
7K followers
1.2K following
320 posts
Harvard/Brigham Infectious Diseases doctor, writer, educator. Editor of Clinical Infectious Diseases. Prefer baseball to football, pizza to sushi, dogs to cats, Beatles to Stones. https://blogs.jwatch.org/hiv-id-observations/
Posts
Media
Videos
Starter Packs
Paul Sax
@paulsaxmd.bsky.social
· Sep 6
Paul Sax
@paulsaxmd.bsky.social
· Sep 5
End-of-Summer Musings -- Hepatitis B, Dalbavancin, Alpha-Gal, and More
The last time I did one of these quick “musings” posts, I listed 21, and someone asked me, “Why 21?” The answer — obviously — is that I originally planned on writing 20, but then had to add a 21st, ju...
blogs.jwatch.org
Paul Sax
@paulsaxmd.bsky.social
· Aug 30
Paul Sax
@paulsaxmd.bsky.social
· Aug 30
Watching the Chaos at the CDC -- with Sadness and Alarm
Throughout my career as an infectious diseases doctor, the CDC has been a rock-solid source. Need reliable data on an outbreak? The CDC. Need thoughtful, evidence-based guidelines? The CDC. Need an au...
blogs.jwatch.org
Paul Sax
@paulsaxmd.bsky.social
· Aug 28
Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti:...
Patients on second-line protease inhibitor-based regimens in low-income and middle-income countries have high rates of nucleoside reverse transcriptas…
www.sciencedirect.com